EGFR and glioblastoma: In support, comparative expression analysis revealed TMZ-resistant GBM cells contained a higher level of stemness markers including Sox2, β-catenin and oncogenic markers, EGFR and CDK6 (Fig. 2e) in both Western blot and q-RT-PCR detection.